The role of endothelial cells in the formation of early metastatic niches in the lung
The role of endothelial cells in the formation of early metastatic niches in the lung
批准号:
10570116
负责人:
Sandra Ryeom
金额:
$10.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-17 至 2023-08-31
中文摘要
总结
转移性疾病是一个多步骤级联反应,是癌症相关死亡的主要原因。许多研究
他们正在研究肿瘤细胞如何获得转移到远处器官并逃离它们的能力。
主要位置。然而,对正常人的定植机制知之甚少。
器官的扩散和循环肿瘤细胞,可以说是转移进展的限速步骤。的
肺是最常见的转移部位之一,因此在本提案中,我们将研究
在循环癌细胞外渗出血管腔期间,正常肺中的内皮细胞(EC)
并定殖到正常肺中以建立肺转移。扩散的肿瘤细胞经历显著的
循环中的压力,使得在外渗到正常肺中期间,它们需要保护性小生境
由细胞外基质组成以提供物理锚定以防止失巢凋亡和凋亡。这个保护
小生境允许播散的肿瘤细胞有机会恢复,存活并最终在肺中扩展
变成大转移病灶我们正在研究激活肺内皮细胞将正常
肺组织进入适宜的“土壤”或早期转移小生境(EMN),以促进循环肿瘤的定植
细胞我们发表的研究和初步数据表明,肺EC在肿瘤到达之前被激活,
小鼠肺转移模型中的细胞。我们的数据还表明,基质细胞糖蛋白,
血小板反应蛋白-1(TSP 1)在转移进展过程中调节EC稳态中起重要作用。
特异性转移至肺的肿瘤细胞和肿瘤条件培养基下调肺中的TSP 1
EC促进EC活化。我们的初步研究确定了基质金属蛋白酶的表达增加,
TSP 1低表达的内皮细胞中MMP-3的表达。我们的初步数据表明,MMP 3促进内皮细胞间质
通过与CD 44的相互作用,最终导致细胞外基质产生和重塑增加,
有助于肺中EMN的产生。我们的首要假设是
原发性肿瘤,
转移到肺通过TSP 1下调激活肺EC,导致EndoMT和增加
EMN中的细胞外基质产生支持肺定植。我们认为TSP 1是一个关键的
EC稳态的调节剂及其丧失促进EC活化并最终导致细胞外基质
通过MMP 3-CD 44轴产生和重塑。了解EC在正常肺中的作用
转移进展将为肺部最早阶段的机制提供新的见解
转移,并可提供用于预防转移性疾病的治疗靶点。
英文摘要
SUMMARY
Metastatic disease is a multistep cascade and is the primary cause of cancer-related mortalities. Many studies
are investigating how tumor cells acquire the ability to metastasize to distant organs and escape from their
primary location. However much less is known about the mechanisms underlying the colonization of normal
organs by disseminated and circulating tumor cells, arguably the rate limiting step in metastatic progression. The
lung is one of the most common sites of metastases therefore in this proposal, we will investigate the role of
endothelial cells (ECs) in the normal lung during extravasation of circulating cancer cells out of the vessel lumen
and colonization into the normal lung to establish lung metastases. Disseminated tumor cells undergo significant
stress in the circulation such that during extravasation into the normal lung, they require a protective niche
composed of extracellular matrix to provide physical anchorage to prevent anoikis and apoptosis. This protective
niche allows disseminated tumor cells the opportunity to recover, survive and expand in the lung eventually
becoming macrometastatic lesions. We are investigating the processes that activate lung ECs converting normal
lung tissue into hospitable “soil” or an early metastatic niche (EMN) to facilitate colonization by circulating tumor
cells. Our published studies and preliminary data suggest that lung ECs are activated prior to the arrival of tumor
cells in mouse models of lung metastases. Our data also indicate that the matricellular glycoprotein,
thrombospondin-1 (TSP1) plays an important role in regulating EC homeostasis during metastatic progression.
Tumor cells that specifically metastasize to the lung and tumor conditioned media downregulates TSP1 in lung
ECs promoting EC activation. Our pilot studies identified increased expression of matrix metalloproteases
(MMPs) 3 in TSP1low ECs. Our preliminary data suggest that MMP3 promotes endothelial-to-mesenchymal
through interactions with CD44 ultimately leading to increased extracellular matrix production and remodeling
contributing to EMN generation in the lung. Our overarching hypothesis is that
primary tumors that
metastasize to the lung activate lung ECs by TSP1 downregulation leading to EndoMT and increased
extracellular matrix production in the EMN supporting lung colonization. We propose that TSP1 is a critical
regulator of EC homeostasis and its loss promotes EC activation and ultimately leads to extracellular matrix
production and remodeling via an MMP3-CD44 axis. Understanding the contribution of ECs in the normal lung
towards metastatic progression will offer new insight into the mechanisms underlying the earliest stages of lung
metastases and may offer therapeutic targets for the prevention of metastatic disease.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2217/fon.09.88
发表时间:
2009-10
期刊:
Future oncology
影响因子:
3.3
作者:
[S. Ryeom;Kwan-Hyuck Baek;A. Zaslavsky]
通讯作者:
S. Ryeom;Kwan-Hyuck Baek;A. Zaslavsky
DOI:
10.1158/1078-0432.ccr-15-1356
发表时间:
2016-02-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Yoon C, Cho SJ, Aksoy BA, Park DJ, Schultz N, Ryeom SW, Yoon SS]
通讯作者:
Yoon SS
DOI:
10.18632/oncotarget.11748
发表时间:
2016-10-04
期刊:
Oncotarget
影响因子:
--
作者:
[Schadler KL, Thomas NJ, Galie PA, Bhang DH, Roby KC, Addai P, Till JE, Sturgeon K, Zaslavsky A, Chen CS, Ryeom S]
通讯作者:
Ryeom S
Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity.
DOI:
10.1186/s40959-021-00100-3
发表时间:
2021-04-19
期刊:
Cardio-oncology (London, England)
影响因子:
--
作者:
[Hoffman RK, Kim BJ, Shah PD, Carver J, Ky B, Ryeom S]
通讯作者:
Ryeom S
DOI:
10.1038/s41467-018-06881-z
发表时间:
2018-10-22
期刊:
Nature communications
影响因子:
16.6
作者:
[Bhang DH, Kim BJ, Kim BG, Schadler K, Baek KH, Kim YH, Hsiao W, Ding BS, Rafii S, Weiss MJ, Chou ST, Kolon TF, Ginsberg JP, Ryu BY, Ryeom S]
通讯作者:
Ryeom S
共 11 条
The role of endothelial cells in the formation of early metastatic niches in the lung
-
批准号:10241023
-
项目类别:
-
资助金额:$1.69万
-
财政年份:2021
-
负责人:Sandra Ryeom
-
依托单位:
Negative Regulation of VEGF-Mediated Angiogenesis
-
批准号:7901792
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
-
批准号:9378981
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Negative Regulation of VEGF-Mediated Angiogenesis
-
批准号:8073963
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Negative Regulation of VEGF-Mediated Angiogenesis
-
批准号:7652961
-
项目类别:
-
资助金额:$2.15万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Negative Regulation of VEGF-Mediated Angiogenesis
-
批准号:7778284
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Negative Regulation of VEGF-Mediated Angiogenesis
-
批准号:8248591
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Negative Regulation of VEGF-Mediated Angiogenesis
-
批准号:8462223
-
项目类别:
-
资助金额:$27.24万
-
财政年份:2009
-
负责人:Sandra Ryeom
-
依托单位:
Project 4 - Characterizing and Overcoming Resistance to ERBB2 Directed Therapy in Metastatic Gastric and Esophageal Adenocarcinoma
-
批准号:10456161
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2007
-
负责人:Sandra Ryeom
-
依托单位:
Z0 1 SIGNALING IN CORNEAL EPITHELIAL CELL BIOLOGY
-
批准号:6087578
-
项目类别:
-
资助金额:$3.92万
-
财政年份:1999
-
负责人:Sandra Ryeom
-
依托单位:
Z0 1 SIGNALING IN CORNEAL EPITHELIAL CELL BIOLOGY
-
批准号:2824622
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1998
-
负责人:Sandra Ryeom
-
依托单位:
Z0 1 SIGNALING IN CORNEAL EPITHELIAL CELL BIOLOGY
-
批准号:2520460
-
项目类别:
-
资助金额:$2.54万
-
财政年份:1998
-
负责人:Sandra Ryeom
-
依托单位:
Tumor Biology Program
-
批准号:10088743
-
项目类别:
-
资助金额:$8.31万
-
财政年份:1997
-
负责人:Sandra Ryeom
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
-
批准号:82371605
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:蒋君涛
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
血管内皮细胞源性的外泌体通过Notch信号通路增强肿瘤细胞可塑性的机制研究
-
批准号:32100627
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张宇
-
依托单位:
低剂量辐射通过CXCR4途径介导糖尿病大鼠内皮祖细胞的归巢机制
-
批准号:81300660
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:郭蔚莹
-
依托单位:
IL-33/ST2信号转导通路对脂多糖诱导肺微血管内皮细胞旁通透性变化的影响及机制研究
-
批准号:81171639
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:谢俊然
-
依托单位:
MK调控EPCR表达在肿瘤血管形成中的作用研究
-
批准号:81101493
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:王庆苓
-
依托单位:
PPARγ转录阻遏NF-κB通路抗高(血)糖诱导血管内皮胰岛素抵抗的作用及机制
-
批准号:81070633
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:黄起壬
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位:
趋化因子及其受体介导的血源性干/祖细胞及血管内皮细胞在新生血管性眼病中免疫病理机制及干预
-
批准号:30972712
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:陆培荣
-
依托单位: